Related Stories

TMB Proposed Rules on Abortion Ban Exceptions Invite TMA Opposition - 05/14/2024

The Texas Medical Board (TMB) recently released proposed rules intended to clarify exceptions to the state’s overlapping abortion laws. But TMA argues the proposal could exacerbate physician confusion, administrative burden on practices, and patient care delays. Read more.

Seeking Balance: TMA Opposes Feds' Implementation of the No Surprises Act - 04/09/2024

The Texas Medical Association supported the patient protections in the federal No Surprises Act but also knew from the beginning that the law's payment arbitration provisions were flawed and could give insurers an advantage.

RICO Settlements: TMA's Leadership Against Payer Abuses Resulted in Relief, Reform - 04/09/2024

Back in 2001, the Texas Medical Association and the other plaintiffs alleged the nation’s major health plans had conspired to delay and reduce payments to clinicians and hospitals; the resulting lawsuits, brought under the federal Racketeer Influenced and Corrupt Organizations Act (RICO), represented a watershed moment in TMA history.

Exceptional Circumstances: TMA Advocates “Legislative Clarity” Amid State Abortion Bans - 03/05/2024

TMA advocates “legislative clarity” amid state abortion bans.

Did You Receive an Email Requiring Registration to the State’s PMP? - 02/28/2024

TMA can confirm that an email sent Friday afternoon asking physicians to register for a PMP Aware account are indeed legitimate; however, there is no deadline to register.

You Write Scripts? You Better Sign Up With the PMP - 02/28/2024

If you don't yet have a user account set up with the state's prescription monitoring program (PMP), known as PMP Aware, now is a good time to get it done.

Cannabidiol Takes a Big Step Toward Respectability - 01/25/2024

In September, the DEA issued an order listing all drugs approved by the U.S. Food and Drug Administration that contain cannabidiol but no more than 0.1 percent of the chief psychoactive agent in cannabis as Schedule V drugs — those with the least potential for abuse. So far, Epidiolex is the only medication that fits that description.

Help Promote National Drug Prescription Take Back Day on Oct. 28 - 10/19/2023

Prescription Drug Take Back Day, which allows people to dispose of prescription drugs safely and anonymously, is scheduled for Oct. 26 at locations throughout the state.

Noncompete Concerns Spark Ongoing TMA Advocacy, Resources - 09/19/2023

The Texas Medical Association continues to receive reports of physician concerns over noncompete agreements, underscoring medicine’s ongoing legislative and regulatory advocacy efforts to strike a balance that works for physician employers and employed physicians alike.

Practice E-Tips on Legal Topics - 07/20/2023

TMA Practice E-Tips on Legal Topics

Physicians Will Lead Legislature’s Controlled Substances Committee - 07/17/2023

When a special joint committee of the Texas Legislature tackles issues with controlled substances this year, physician-lawmakers will take the lead.

Medicare Part B Inflation Rebate Takes Effect, Lowering Copays - 06/27/2023

A new federal law requires drug companies to rebate Medicare if they raise certain drug prices higher than the rate of inflation, which has translated into lower copays for some Medicare patients.

Fighting Back: Practice Wins Court Battle Over Defamatory Online Reviews - 06/20/2023

One practice’s recent legal battle epitomizes physicians’ worst nightmares when it comes to online reviews. Here’s an extreme but glaring real world example, straight from the documents in a lawsuit that Austin Eye first filed in October 2017 over

TMA Asks AMA to Stay Out of Affordable Care Act Suit - 05/02/2023

Leaders of the Texas Medical Association on Tuesday publicly objected to the American Medical Association’s plans to get involved in a high-profile federal lawsuit — filed in Texas — challenging the constitutionality of the Affordable Care Act.

TMA Analyzes FTC Proposed Ban on Noncompetes - 03/09/2023

The interplay between federal and state efforts to ban noncompete agreements remains unclear as Texas Medical Association experts analyze a proposed Federal Trade Commission (FTC) rule on the matter.

DEA Proposed Rules Address Telehealth Prescribing Post PHE - 03/08/2023

Physicians found new flexibility in prescribing controlled substances via telemedicine during the COVID-19 pandemic. Now that the public health emergency is ending, the Drug Enforcement Administration (DEA) has proposed new rules for prescribers it says could preserve some of those flexibilities “with appropriate safeguards.”

Risk Management - 02/15/2023

Practice e-Tips on Risk Management

Pharmacy Rule Opens Door to Improve Access to Low-Cost Medications - 02/06/2023

Given the high cost of medications, pharmacies should be sharing low-cost options with patients and allowing them to transfer their prescriptions as needed – without imposing additional administrative hassles on physician practices.

Counterfeit Medications Proliferate in Patient Care – and They’re Not Just Illicit Opioids - 01/31/2023

Counterfeit medications are a growing problem that can undermine medical treatment, and all physicians can help prevent their spread by asking patients simple questions.

TMB Rewrites Rule to Improve Chronic Pain Care for Texas Patients - 01/19/2023

The Texas Medical Board recently revised one of its rules in a way that makes it easier for physician practices to provide more comprehensive pain management.

Help, Not Discipline: TMB Program Guides Physicians Through Impairment - 11/01/2022

The Texas Physician Health Program helps physicians work through mental health crises and avoid discipline by the Texas Medical Board.

Nationwide Adderall Shortage Expected to Last Through 2022 - 10/31/2022

The U.S. Food and Drug Administration (FDA) expects a nationwide shortage of Adderall and Adderall IR to extend through the end of the year, following manufacturing delays by the largest producer of Adderall in the country, Teva Pharmaceuticals LLC.

TMA Urges CMS to Nix Penalties Related to E-Prescribing Controlled Substances - 10/14/2022

The Texas Medical Association is pushing back against proposed penalties for physicians who don’t electronically prescribe controlled substances.

Are You Ready for Changes to Opioid Prescribing in Texas? - 10/14/2022

Beginning Sept. 1, all prescribers will be required to set up an account with the state’s prescription monitoring program, known as PMP Aware. The Texas State Board of Pharmacy will also begin issuing new official prescription forms that include advanced security features designed to help deter fraud.

Compact for Care: Texas Joins Interstate Agreement for Out-of-State Licensure - 10/13/2022

The rise of telemedicine during the COVID-19 pandemic has spurred a change in state law that will not only help make certain telemedicine services permanent but also give out-of-state physicians an easier pathway to join the Texas workforce.